Grantham, Mayo, Van Otterloo & Co (GMO)
PRNB

Grantham, Mayo, Van Otterloo & Co (GMO)’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-34,600
Closed -$2.06M – 856
2020
Q1 		$2.06M Buy
+34,600
New +$2.02M 0.02% 381

Other funds holding PRNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s PRNB Position: Q2 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q2 2020, closing a stake of 34,600 shares — an estimated $2.06M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PRNB in Q1 2020 and held it in 1 quarter. The position peaked at $2.06M in Q1 2020. 137 funds tracked by Wall St. Rank hold PRNB as of Q2 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Principia Biopharma Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 34,600 Principia Biopharma Inc. Common Stock shares in Q2 2020, an estimated $2.06M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Principia Biopharma Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Principia Biopharma Inc. Common Stock position peaked at $2.06M in Q1 2020.
  • 137 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q2 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2020, filed 13 Aug 2020.